Laboratory Corp. Of America Holdings Share Price: LH (Laboratory Corp. Of America Holdings) Stock Price Today & Updates | INDmoney

Question 1

What is Laboratory Corp. Of America Holdings share price today?

Accepted Answer

Laboratory Corp. Of America Holdings (LH) share price today is {{live_price}}.

Question 2

Can Indians buy Laboratory Corp. Of America Holdings shares?

Accepted Answer

Yes, Indians can invest in the Laboratory Corp. Of America Holdings (LH) from India.

With INDmoney, you can buy Laboratory Corp. Of America Holdings at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Laboratory Corp. Of America Holdings at zero transaction cost.

Question 3

How can I buy Laboratory Corp. Of America Holdings shares from India?

Accepted Answer

It is very easy to buy Laboratory Corp. Of America Holdings from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Laboratory Corp. Of America Holdings be purchased?

Accepted Answer

Yes, you can buy fractional shares of Laboratory Corp. Of America Holdings with INDmoney app.

Question 5

What are the documents required to start investing in Laboratory Corp. Of America Holdings stocks?

Accepted Answer

To start investing in Laboratory Corp. Of America Holdings, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Laboratory Corp. Of America Holdings

Accepted Answer

Today’s highest price of Laboratory Corp. Of America Holdings (LH) is {{1_rba_end}}.

Today’s lowest price of Laboratory Corp. Of America Holdings (LH) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Laboratory Corp. Of America Holdings

Accepted Answer

Today's market capitalisation of Laboratory Corp. Of America Holdings LH is 20.1B

Question 8

What is the 52 Week High and Low Range of Laboratory Corp. Of America Holdings

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Laboratory Corp. Of America Holdings is down from its 52 Week High?

Accepted Answer

Laboratory Corp. Of America Holdings (LH) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Laboratory Corp. Of America Holdings is up from its 52 Week low?

Accepted Answer

Laboratory Corp. Of America Holdings (LH) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Laboratory Corp. Of America Holdings?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Laboratory Corp. Of America Holdings

Accepted Answer

Mr. Adam H. Schechter is the current Chief Executive Officer (CEO) of Laboratory Corp. Of America Holdings.

Period	Laboratory Corp. Of America Holdings	Sector (Health Care)	S&P500
3 Months	4.12%	-7.3%	5.9%
6 Months	20.05%	-0.2%	12.5%
1 Year	12.67%	9.9%	30.9%
3 Years	-15.53%	8.8%	27.0%

Market Capitalization	20.1B
Book Value	$97.61
Dividend Share	2.88
Dividend Yield	1.2%
Earnings Per Share (EPS)	5.26
PE Ratio	45.66
PEG Ratio	0.51
Wall Street Target Price	261.25

Profit Margin	3.43%
Operating Margin TTM	8.29%

Return On Assets TTM	3.96%
Return On Equity TTM	5.43%

Revenue TTM	12.7B
Revenue Per Share TTM	151.03
Quarterly Revenue Growth YOY	7.3999999999999995%
Gross Profit TTM	4.4B
EBITDA	1.7B
Diluted Eps TTM	5.26
Quarterly Earnings Growth YOY	-0.05

Laboratory Corp. Of America Holdings (LH)

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Company Financials

Technicals Summary

Peers

Increasing Revenue

Decreasing Net Profit

Institutional Holdings

Corporate Announcements

Laboratory Corp. Of America Holdings Dividends March,2024

Company Information

Discover More

FAQs

EPS Estimate Current Year	14.53
EPS Estimate Next Year	15.98
EPS Estimate Current Quarter	3.48
EPS Estimate Next Quarter	3.44

	FY18	Y/Y Change
Revenue	11.3B	↑ 8.54%
Net Income	883.7M	↓ 30.32%
Net Profit Margin	7.8%	↓ 4.35%

	FY19	Y/Y Change
Revenue	11.6B	↑ 1.95%
Net Income	823.8M	↓ 6.78%
Net Profit Margin	7.13%	↓ 0.67%

	FY20	Y/Y Change
Revenue	14.0B	↑ 20.98%
Net Income	1.6B	↑ 88.89%
Net Profit Margin	11.13%	↑ 4.0%

	FY21	Y/Y Change
Revenue	16.1B	↑ 15.33%
Net Income	2.4B	↑ 52.77%
Net Profit Margin	14.75%	↑ 3.62%

	FY22	Y/Y Change
Revenue	14.9B	↓ 7.72%
Net Income	1.3B	↓ 46.2%
Net Profit Margin	8.6%	↓ 6.15%

	FY23	Y/Y Change
Revenue	12.2B	↓ 18.25%
Net Income	418.0M	↓ 67.32%
Net Profit Margin	3.44%	↓ 5.16%

	Q2 FY23	Q/Q Change
Revenue	3.0B	↓ 19.7%
Net Income	188.9M	↓ 11.27%
Net Profit Margin	6.23%	↑ 0.59%

	Q3 FY23	Q/Q Change
Revenue	3.1B	↑ 0.76%
Net Income	183.3M	↓ 2.96%
Net Profit Margin	6.0%	↓ 0.23%

	Q4 FY23	Q/Q Change
Revenue	3.0B	↓ 0.77%
Net Income	-167.1M	↓ 191.16%
Net Profit Margin	-5.51%	↓ 11.51%

	FY18	Y/Y Change
Total Assets	16.2B	↓ 2.31%
Total Liabilities	9.2B	↓ 5.38%

	FY19	Y/Y Change
Total Assets	18.0B	↑ 11.34%
Total Liabilities	10.5B	↑ 13.46%

	FY21	Y/Y Change
Total Assets	20.4B	↑ 1.56%
Total Liabilities	10.1B	↓ 5.6%

	FY22	Y/Y Change
Total Assets	20.2B	↓ 1.13%
Total Liabilities	10.1B	↓ 0.53%

	Q1 FY24	Q/Q Change
Revenue	3.2B	↑ 4.72%
Net Income	228.0M	↓ 236.45%
Net Profit Margin	7.18%	↑ 12.69%

	Q2 FY24	Q/Q Change
Revenue	3.2B	↑ 1.39%
Net Income	205.3M	↓ 9.96%
Net Profit Margin	6.37%	↓ 0.81%

	Q3 FY24	Q/Q Change
Revenue	3.3B	↑ 1.9%
Net Income	169.3M	↓ 17.54%
Net Profit Margin	5.16%	↓ 1.21%

	FY18	Y/Y Change
Operating Cash Flow	1.3B	↓ 10.55%
Investing Cash Flow	206.7M	↓ 109.27%
Financing Cash Flow	-1.4B	↓ 319.96%

	FY19	Y/Y Change
Operating Cash Flow	1.4B	↑ 10.67%
Investing Cash Flow	-1.3B	↓ 720.75%
Financing Cash Flow	-252.7M	↓ 81.82%

	FY20	Y/Y Change
Operating Cash Flow	2.1B	↑ 47.8%
Investing Cash Flow	-643.2M	↓ 49.87%
Financing Cash Flow	-517.4M	↑ 104.75%

	FY21	Y/Y Change
Operating Cash Flow	3.1B	↑ 45.63%
Investing Cash Flow	-884.6M	↑ 37.53%
Financing Cash Flow	-2.1B	↑ 299.27%

	FY22	Y/Y Change
Operating Cash Flow	2.0B	↓ 37.1%
Investing Cash Flow	-1.7B	↑ 86.77%
Financing Cash Flow	-1.3B	↓ 36.0%

	Q2 FY23	Q/Q Change
Operating Cash Flow	351.4M	↑ 189.93%
Investing Cash Flow	-353.3M	↑ 254.36%
Financing Cash Flow	1.5B	↓ 2649.5%

	Q3 FY23	Q/Q Change
Operating Cash Flow	275.5M	↓ 21.6%
Investing Cash Flow	-840.9M	↑ 138.01%
Financing Cash Flow	-987.8M	↓ 163.94%

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Laboratory Corp. Of America Holdings	4.17%	20.05%	12.67%	-15.53%	38.71%
Idexx Laboratories, Inc.	-7.75%	-19.22%	-12.74%	-32.97%	65.66%
Agilent Technologies Inc.	2.41%	-11.16%	5.7%	-12.51%	66.76%
Thermo Fisher Scientific, Inc.	-7.92%	-12.12%	4.58%	-18.92%	65.25%
Danaher Corp.	-4.9%	-10.25%	6.52%	-25.24%	62.72%
Iqvia Holdings Inc.	-4.67%	-12.1%	-4.81%	-23.94%	37.77%

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Laboratory Corp. Of America Holdings	Buy	$20.1B	38.71%	45.66	3.43%
Idexx Laboratories, Inc.	Buy	$34.3B	65.66%	40.32	22.53%
Agilent Technologies Inc.	Buy	$37.9B	66.76%	27.46	21.75%
Thermo Fisher Scientific, Inc.	Buy	$197.4B	65.25%	32.36	14.48%
Danaher Corp.	Buy	$169.8B	62.72%	44.43	16.39%
Iqvia Holdings Inc.	Buy	$36.6B	37.77%	26.52	9.17%

Organization	Laboratory Corp. Of America Holdings
Employees	67000
CEO	Mr. Adam H. Schechter
Industry	Health Services